Akebia Therapeutics | AKBA - Market Capitalization


Akebia Therapeutics reported $232.4M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Astellas Pharma JPY 4.56T 770.92B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Exelixis USD 10.89B 857M Mar/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.57B 225M Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Zealand Pharma A/S 33.35B 448.34M Dec/2025